Skip to content
Review Open access

High-Flow Nasal Cannula Versus Non-Invasive Ventilation in Immunocompromised Adults with Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Sep 2026 · Journal of Saidu Medical College · Vol 16 · 0 citations

TL;DR

High flow nasal cannula may yield a potential improvement in survival and reduce intubation risk in immunocompromised patients with ARF while maintaining comparable clinical outcomes to NIV.

Abstract

Background & Objective: Acute respiratory failure (ARF) is a typical cause of intensive care unit (ICU) admission and is linked with substantial morbidity and mortality, particularly among immunocompromised patients. Noninvasive ventilation (NIV) has been employed to avoid invasive mechanical ventilation; however, high-flow nasal cannula (HFNC) oxygen therapy has proved itself as an effective alternative. Evidence comparing the response of HFNC and NIV in immunocompromised patients with ARF remains inconsistent. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of HFNC compared with NIV in immunocompromised adults with acute hypoxemic respiratory failure. Methodology: A comprehensive search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was conducted from database inception to October 2024. Randomized controlled trials and observational studies comparing HFNC with NIV in immunocompromised adults with ARF were included. The primary outcomes were the incidence of endotracheal intubation and mortality. The secondary outcomes that were analyzed include ventilator duration, ICU length of stay, hospital length of stay, and adverse events. Pooled analyses were performed utilizing a random effects model, with risk ratios (RR) or mean differences (MD) and 95% confidence intervals (CI). Results: Six studies comprising 432 patients (217 HFNC and 215 NIV) were included. HFNC was linked with a non-significant decline in the risk of intubation (RR 0.77, 95% CI 0.51–1.16) and a borderline decrease in mortality (RR 0.73, 95% CI 0.53–1.00). Both interventions showed comparable results in outcomes, like ventilator duration, ICU stay, or hospital stay. HFNC resulted in fewer adverse events compared with NIV, although the difference was not statistically significant. Conclusion: HFNC may yield a potential improvement in survival and reduce intubation risk in immunocompromised patients with ARF while maintaining comparable clinical outcomes to NIV. Future large-scale randomized studies are required to establish the reliability of these findings. Key Words: High flow nasal cannula, Non invasive ventilation, Acute respiratory failure.

Read PDF

Similar papers

Review Open access Nov 2026

High-flow nasal oxygen versus non-invasive ventilation in patients with acute hypercapnic exacerbation of COPD: a systematic review and meta-analysis of randomised controlled trials

Abstract Background Acute exacerbations of chronic obstructive pulmonary disease complicated by acute hypercapnia require respiratory support. Respiratory acidosis requires support that is often provided with high-flow nasal oxygen (HFNO) or non-invasive ventilation (NIV). Our aim is to compare the efficacy and safety...

Paraschos Archontakis-Barakakis, M. Sovani, R. Eric et al. · 0 citations
Review Nov 2026

Abstract 9083: Efficacy and Safety of High-Flow Nasal Cannula vs. Other Oxygenation Techniques in Cardiogenic Pulmonary Edema: A Systematic Review and Meta-Analysis

Background: Cardiogenic pulmonary edema is a common cause of acute respiratory failure and requires rapid respiratory support to improve oxygenation and breathing. Noninvasive ventilation has traditionally been used first-line in this setting; however, high-flow nasal cannula (HFNC) has emerged as a potentially bett...

Y. Oliinyk, Ashrika Sookoo, Ajmal Ali et al. · 0 citations
Open access Oct 2026

High-flow nasal cannula versus high-velocity nasal insufflation for weaning from mechanical ventilation in respiratory intensive care unit: a randomized clinical trial

High-velocity nasal insufflation and High-flow nasal cannula initiated immediately postextubation versus NIV represent effective and better-tolerated alternatives to NIV for postextubation respiratory support, with similar short-term clinical outcomes.

Montaser G. Ahmed, A. Hussein, W. Khaleel · 0 citations
Review Oct 2026

Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review.

INTRODUCTION Chronic obstructive pulmonary disease is a common lung disease. Acute exacerbations (AECOPD) are associated with increased hospitalisations and mortality. Current guidelines provide only conditional recommendation for the use of High Flow Nasal Cannula (HFNC) supported by low-certainty evidence in hypercap...

Muzat Reyim, Stéphane Mouraux, P. Tankéré et al. · 0 citations
Review Nov 2026

Abstract 11093: Comparing High-Flow Nasal Cannula Therapy and Conventional Oxygen Therapy in Adult Patients Post-Cardiac Surgery: A Systematic Review and Meta-Analysis

Introduction/Background: Cardiac surgery frequently precipitates post-operative respiratory complications, increasing ICU admissions, morbidity, and mortality. Conventional Oxygen Therapy (COT) via nasal prongs, facemask, or venturi mask remains standard care but often fails to meet elevated post-operative oxygen de...

Zaryab Bacha, H. Naveed, Syed Umair Ahmed et al. · 0 citations
Review Sep 2026

Non-invasive ventilation (NIV) and high-flow nasal therapy (HFNT) in palliative care: a critical narrative review.

BACKGROUND Dyspnoea is a prevalent, debilitating symptom in advanced life-limiting illnesses. While opioids and non-pharmacological measures remain foundational, refractory breathlessness presents a major palliative challenge. OBJECTIVES To critically appraise the evidence regarding patient selection, comparative tol...

S. Mercadante · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.